INS and type 1 diabetes mellitus: The Master Protocol is based on the analytic backbone that has been established in the INNODIA natural history study, with systematic assessment of beta-cell function, insulin dose, HbA1c, immunological studies and broad biomarker discovery work over the first 2 years from the diagnosis of type 1 diabetes.